Literature DB >> 28074646

Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.

Luis M Blancas-Mejía1, Pinaki Misra1, Marina Ramirez-Alvarado1.   

Abstract

Light chain (AL) amyloidosis is a lethal disease characterized by the deposition of the immunoglobulin light chain into amyloid fibrils, resulting in organ dysfunction and failure. Amyloid fibrils have the ability to self-propagate, recruiting soluble protein into the fibril by a nucleation-polymerization mechanism, characteristic of autocatalytic reactions. Experimental data suggest the existence of a critical concentration for initiation of fibril formation. As such, the initial concentration of soluble amyloidogenic protein is expected to have a profound effect on the rate of fibril formation. In this work, we present in vitro evidence that fibril formation rates for AL light chains are affected by the protein concentration in a differential manner. De novo reactions of the proteins with the fastest amyloid kinetics (AL-09, AL-T05, and AL-103) do not present protein concentration dependence. Seeded reactions, however, exhibited weak protein concentration dependence. For AL-12, seeded and protein concentration dependence data suggest a synergistic effect for recruitment and elongation at low protein concentrations, while reactions of κI exhibited poor efficiency in nucleating and elongating preformed fibrils. Additionally, co-aggregation and cross seeding of κI variable domain (VL) and the κI full length (FL) light chain indicate that the presence of the constant domain in κI FL modulates fibril formation, facilitating the recruitment of κI VL. Together, these results indicate that the dominant process in fibril formation varies among the AL proteins tested with a differential dependence of the protein concentration.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28074646      PMCID: PMC5310643          DOI: 10.1021/acs.biochem.6b01043

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  45 in total

1.  Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation.

Authors:  Evan T Powers; David L Powers
Journal:  Biophys J       Date:  2007-09-21       Impact factor: 4.033

2.  Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.

Authors:  Ara Celi DiCostanzo; James R Thompson; Francis C Peterson; Brian F Volkman; Marina Ramirez-Alvarado
Journal:  J Biol Chem       Date:  2012-06-27       Impact factor: 5.157

3.  The monomer-seed interaction mechanism in the formation of the β2-microglobulin amyloid fibril clarified by solution NMR techniques.

Authors:  Kotaro Yanagi; Kazumasa Sakurai; Yuichi Yoshimura; Tsuyoshi Konuma; Young-Ho Lee; Kenji Sugase; Takahisa Ikegami; Hironobu Naiki; Yuji Goto
Journal:  J Mol Biol       Date:  2012-06-06       Impact factor: 5.469

4.  Kinetic control in protein folding for light chain amyloidosis and the differential effects of somatic mutations.

Authors:  Luis M Blancas-Mejía; Alexander Tischer; James R Thompson; Jonathan Tai; Lin Wang; Matthew Auton; Marina Ramirez-Alvarado
Journal:  J Mol Biol       Date:  2013-10-22       Impact factor: 5.469

5.  Mechanism of thioflavin T binding to amyloid fibrils.

Authors:  Ritu Khurana; Chris Coleman; Cristian Ionescu-Zanetti; Sue A Carter; Vinay Krishna; Rajesh K Grover; Raja Roy; Shashi Singh
Journal:  J Struct Biol       Date:  2005-09       Impact factor: 2.867

Review 6.  Systemic amyloidoses.

Authors:  Luis M Blancas-Mejía; Marina Ramirez-Alvarado
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

Review 7.  Fitting neurological protein aggregation kinetic data via a 2-step, minimal/"Ockham's razor" model: the Finke-Watzky mechanism of nucleation followed by autocatalytic surface growth.

Authors:  Aimee M Morris; Murielle A Watzky; Jeffrey N Agar; Richard G Finke
Journal:  Biochemistry       Date:  2008-02-05       Impact factor: 3.162

8.  Role of mutations in the cellular internalization of amyloidogenic light chains into cardiomyocytes.

Authors:  Rebecca T Levinson; Oludare O Olatoye; Edward G Randles; Kyle G Howell; Ara Celi DiCostanzo; Marina Ramirez-Alvarado
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 9.  Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases.

Authors:  Rodrigo Morales; Ines Moreno-Gonzalez; Claudio Soto
Journal:  PLoS Pathog       Date:  2013-09-19       Impact factor: 6.823

10.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism.

Authors:  Samuel I A Cohen; Sara Linse; Leila M Luheshi; Erik Hellstrand; Duncan A White; Luke Rajah; Daniel E Otzen; Michele Vendruscolo; Christopher M Dobson; Tuomas P J Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-23       Impact factor: 11.205

View more
  8 in total

1.  Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time.

Authors:  Kian Kamgar-Parsi; Liu Hong; Akira Naito; Charles L Brooks; Ayyalusamy Ramamoorthy
Journal:  J Biol Chem       Date:  2017-07-24       Impact factor: 5.157

2.  Kinetic stability and sequence/structure studies of urine-derived Bence-Jones proteins from multiple myeloma and light chain amyloidosis patients.

Authors:  Luis M Blancas-Mejía; Emily B Martin; Angela Williams; Jonathan S Wall; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2017-09-01       Impact factor: 2.352

3.  Mechanistic Insights into the Early Events in the Aggregation of Immunoglobulin Light Chains.

Authors:  Pinaki Misra; Luis M Blancas-Mejia; Marina Ramirez-Alvarado
Journal:  Biochemistry       Date:  2019-07-09       Impact factor: 3.162

Review 4.  Immunoglobulin light chain amyloid aggregation.

Authors:  Luis M Blancas-Mejia; Pinaki Misra; Christopher J Dick; Shawna A Cooper; Keely R Redhage; Michael R Bergman; Torri L Jordan; Khansaa Maar; Marina Ramirez-Alvarado
Journal:  Chem Commun (Camb)       Date:  2018-09-20       Impact factor: 6.222

Review 5.  Animal models of monoclonal immunoglobulin-related renal diseases.

Authors:  Christophe Sirac; Guillermo A Herrera; Paul W Sanders; Vecihi Batuman; Sebastien Bender; Maria V Ayala; Vincent Javaugue; Jiamin Teng; Elba A Turbat-Herrera; Michel Cogné; Guy Touchard; Nelson Leung; Frank Bridoux
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

6.  Structural mapping of oligomeric intermediates in an amyloid assembly pathway.

Authors:  Theodoros K Karamanos; Matthew P Jackson; Antonio N Calabrese; Sophia C Goodchild; Emma E Cawood; Gary S Thompson; Arnout P Kalverda; Eric W Hewitt; Sheena E Radford
Journal:  Elife       Date:  2019-09-25       Impact factor: 8.140

7.  The Impact of Halogenated Phenylalanine Derivatives on NFGAIL Amyloid Formation.

Authors:  Suvrat Chowdhary; Johann Moschner; Dorian J Mikolajczak; Maximilian Becker; Andreas F Thünemann; Claudia Kästner; Damian Klemczak; Anne-Katrin Stegemann; Christoph Böttcher; Pierangelo Metrangolo; Roland R Netz; Beate Koksch
Journal:  Chembiochem       Date:  2020-09-23       Impact factor: 3.164

8.  Desmin forms toxic, seeding-competent amyloid aggregates that persist in muscle fibers.

Authors:  Niraja Kedia; Khalid Arhzaouy; Sara K Pittman; Yuanzi Sun; Mark Batchelor; Conrad C Weihl; Jan Bieschke
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-01       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.